We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $491.44, moving +1.21% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.43%. Elsewhere, the Dow lost 0.34%, while the tech-heavy Nasdaq lost 0.62%.
Coming into today, shares of the largest U.S. health insurer had lost 2.52% in the past month. In that same time, the Medical sector lost 3.51%, while the S&P 500 lost 6.57%.
UnitedHealth Group will be looking to display strength as it nears its next earnings release. In that report, analysts expect UnitedHealth Group to post earnings of $5.39 per share. This would mark year-over-year growth of 1.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $78.56 billion, up 11.92% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $21.70 per share and revenue of $319.27 billion. These totals would mark changes of +14.09% and +11.01%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 22.38. This valuation marks a premium compared to its industry's average Forward P/E of 17.83.
It is also worth noting that UNH currently has a PEG ratio of 1.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.25 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 232, which puts it in the bottom 9% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow UNH in the coming trading sessions, be sure to utilize Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $491.44, moving +1.21% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.43%. Elsewhere, the Dow lost 0.34%, while the tech-heavy Nasdaq lost 0.62%.
Coming into today, shares of the largest U.S. health insurer had lost 2.52% in the past month. In that same time, the Medical sector lost 3.51%, while the S&P 500 lost 6.57%.
UnitedHealth Group will be looking to display strength as it nears its next earnings release. In that report, analysts expect UnitedHealth Group to post earnings of $5.39 per share. This would mark year-over-year growth of 1.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $78.56 billion, up 11.92% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $21.70 per share and revenue of $319.27 billion. These totals would mark changes of +14.09% and +11.01%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Investors should also note UnitedHealth Group's current valuation metrics, including its Forward P/E ratio of 22.38. This valuation marks a premium compared to its industry's average Forward P/E of 17.83.
It is also worth noting that UNH currently has a PEG ratio of 1.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 1.25 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 232, which puts it in the bottom 9% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow UNH in the coming trading sessions, be sure to utilize Zacks.com.